0Suppliers
18Customers
2Debt Items
20Related Chains

Source-Backed Evidence Depth

Polyrizon Ltd. (PLRZ) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

21Total relationships
1Distinct source URLs
3High confidence
0.708Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Polyrizon Ltd. Suppliers

No suppliers on recordPolyrizon Ltd. has not yet been matched to upstream suppliers in our database, or is still being processed.

Polyrizon Ltd. Customers

TickerNameConfidenceEvidence
CMND Clearmind Medicine Inc. 72% beling or product candidates insert requirements of the FDA or other regulatory authorities, including any limitations or warnings contained in a product candidate’s approved labeling; ● distribution…
CMND Clearmind Medicine Inc. 72% Reciprocal relationship from CMND graph: Reciprocal relationship from PLRZ graph: beling or product candidates insert requirements of the FDA or other regulatory authorities, including any limitation…
FRSX Foresight Autonomous Holdings Ltd. 72% acement closed on April 1, 2025. On the same date, we entered into an exchange agreement with certain holders of warrants issued in October 2024. Under the agreement, the holders exchanged their exis…
FRSX Foresight Autonomous Holdings Ltd. 72% Reciprocal relationship from FRSX graph: Reciprocal relationship from PLRZ graph: Reciprocal relationship from FRSX graph: Reciprocal relationship from PLRZ graph: Reciprocal relationship from FRSX g…
RVSN Rail Vision Ltd. 72% acement closed on April 1, 2025. On the same date, we entered into an exchange agreement with certain holders of warrants issued in October 2024. Under the agreement, the holders exchanged their exis…
RVSN Rail Vision Ltd. 72% Reciprocal relationship from RVSN graph: Reciprocal relationship from PLRZ graph: Reciprocal relationship from RVSN graph: Reciprocal relationship from PLRZ graph: Reciprocal relationship from RVSN g…
SNYNF Sanofi 72% beling or product candidates insert requirements of the FDA or other regulatory authorities, including any limitations or warnings contained in a product candidate’s approved labeling; ● distribution…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from PLRZ graph: beling or product candidates insert requirements of the FDA or other regulatory authorities, including any limitatio…
SPRC SciSparc Ltd. 72% Reciprocal relationship from SPRC graph: Reciprocal relationship from PLRZ graph: Reciprocal relationship from SPRC graph: Reciprocal relationship from PLRZ graph: acement closed on April 1, 2025. On…
SPRC SciSparc Ltd. 72% acement closed on April 1, 2025. On the same date, we entered into an exchange agreement with certain holders of warrants issued in October 2024. Under the agreement, the holders exchanged their exis…
AEGIS-CAPITAL-CORP AEGIS-CAPITAL-CORP 62% tain prescription drugs based on a drug’s AWP. In the past several years, state and federal government agencies have conducted ongoing investigations of manufacturers’ reporting practices with respec…
EMERGING-GROWTH-COMPANY EMERGING-GROWTH-COMPANY 62% r commercialize our product candidates. ● The misuse or off-label use of our product candidates may harm our reputation in the marketplace, result in injuries that lead to product candidates liabilit…
HIKE-CAPITAL-INC HIKE-CAPITAL-INC 62% ere has been no significant change in the percentage ownership held by any major shareholder since January 1, 2023. The major shareholders listed above do not have voting rights with respect to their…
L-I-A-PURE-CAPITAL-LTD L-I-A-PURE-CAPITAL-LTD 62% ere has been no significant change in the percentage ownership held by any major shareholder since January 1, 2023. The major shareholders listed above do not have voting rights with respect to their…
PHARMASEED-LTD PHARMASEED-LTD 62% beling or product candidates insert requirements of the FDA or other regulatory authorities, including any limitations or warnings contained in a product candidate’s approved labeling; ● distribution…
REUVEN-SRUGO-CONSTRUCTION-COMPANY-LTD REUVEN-SRUGO-CONSTRUCTION-COMPANY-LTD 62% ere has been no significant change in the percentage ownership held by any major shareholder since January 1, 2023. The major shareholders listed above do not have voting rights with respect to their…
TAURUS-GOLD-CORP TAURUS-GOLD-CORP 62% ere has been no significant change in the percentage ownership held by any major shareholder since January 1, 2023. The major shareholders listed above do not have voting rights with respect to their…
XYLO-TECHNOLOGIES-LTD XYLO-TECHNOLOGIES-LTD 62% ere has been no significant change in the percentage ownership held by any major shareholder since January 1, 2023. The major shareholders listed above do not have voting rights with respect to their…

Polyrizon Ltd. Debt Obligations

InstrumentDescriptionConfidenceEvidence
PLRZ-DEBT-11806 Warrants outstanding: 1e-05 90% xbrl warrant detail from xbrl 2025-06-30.
PLRZ-DEBT-11807 Xbrl Convertible 90% xbrl convertible detail from xbrl 2024-12-31.

Polyrizon Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Polyrizon Ltd..

Polyrizon Ltd. Ownership

HolderNameConfidenceEvidence
PLRZ-OWNER-FNY-INVESTMENT-ADVISERS-LLC FNY Investment Advisers, LLC 90% 13F overlay lists FNY Investment Advisers, LLC as top holder; 4 tracked holders.

Polyrizon Ltd. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
ATOS Atossa Therapeutics, Inc. 100.00 2
CMND Clearmind Medicine Inc. 100.00 1 ['customer']
ALXO ALX Oncology Holdings Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
SVA Sinovac Biotech Ltd. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
AMT American Tower Corporation 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
🔐
PLRZ
Unlock PLRZ Supply Chain Data
Verified relationships include:
CMNDClearmind Medicine Inc.Customer72%
CMNDClearmind Medicine Inc.Customer72%
+17 more relationships locked
Subscribe — View plans →